Vivoryon Therapeutics N.V.
4 clinical trials · Sponsor
◉ Watch Vivoryon Therapeutics N.V.
| Record | Firm | Date |
|---|---|---|
| A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early AD (NCT03919162) | Vivoryon Therapeutics N.V. | 2021-11-15 |
| A Study to Evaluate Safety and Tolerability of Different Doses and Efficacy of PQ912 in Subjects With MCI and Mild AD (NCT04498650) | Vivoryon Therapeutics N.V. | 2020-07-06 |
| Safety and Tolerability of PQ912 in Subjects With Early Alzheimer's Disease (NCT02389413) | Vivoryon Therapeutics N.V. | 2015-03-01 |
| Effects of PQ912 on the Pharmacokinetics of Midazolam and Omeprazole (NCT02190708) | Vivoryon Therapeutics N.V. | 2014-06-01 |
Track Vivoryon Therapeutics N.V. automatically
Every clearance here is in the API, with alerts when new ones post.